DE602007011409D1 - Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkultur - Google Patents
Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkulturInfo
- Publication number
- DE602007011409D1 DE602007011409D1 DE602007011409T DE602007011409T DE602007011409D1 DE 602007011409 D1 DE602007011409 D1 DE 602007011409D1 DE 602007011409 T DE602007011409 T DE 602007011409T DE 602007011409 T DE602007011409 T DE 602007011409T DE 602007011409 D1 DE602007011409 D1 DE 602007011409D1
- Authority
- DE
- Germany
- Prior art keywords
- pancreas
- cells
- propulation
- clearer
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/74—Alginate
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76044506P | 2006-01-20 | 2006-01-20 | |
PCT/US2007/001555 WO2007084730A2 (en) | 2006-01-20 | 2007-01-18 | Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602007011409D1 true DE602007011409D1 (de) | 2011-02-03 |
Family
ID=38288290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602007011409T Active DE602007011409D1 (de) | 2006-01-20 | 2007-01-18 | Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkultur |
Country Status (8)
Country | Link |
---|---|
US (1) | US9745554B2 (de) |
EP (1) | EP1994140B1 (de) |
JP (1) | JP5459823B2 (de) |
AT (1) | ATE492629T1 (de) |
AU (1) | AU2007207434B2 (de) |
CA (1) | CA2637843C (de) |
DE (1) | DE602007011409D1 (de) |
WO (1) | WO2007084730A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2923160B1 (fr) * | 2007-11-02 | 2013-07-26 | Pasteur Institut | Composes destines a prevenir ou traiter une infection virale. |
CN103827303B (zh) | 2011-09-26 | 2021-10-22 | 普瑞阿那利提克斯有限公司 | 细胞外核酸的稳定化和分离 |
US11021733B2 (en) | 2011-09-26 | 2021-06-01 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
CN102589955A (zh) * | 2012-01-15 | 2012-07-18 | 中国人民解放军第四军医大学 | 一种检测体液细胞中结核杆菌的染色试剂盒 |
CA2884915C (en) | 2012-09-25 | 2022-05-17 | Qiagen Gmbh | Stabilisation of biological samples |
US20150361400A1 (en) * | 2013-01-25 | 2015-12-17 | Wake Forest University Health Sciences | Compositions and methods for maintaining and improving pancreatic islet cell function and stability |
US11525155B2 (en) | 2013-03-18 | 2022-12-13 | Qiagen Gmbh | Stabilisation of biological samples |
US20160281133A1 (en) | 2013-03-18 | 2016-09-29 | Qiagen Gmbh | Stabilization and isolation of extracellular nucleic acids |
DE202014011287U1 (de) | 2013-06-11 | 2019-02-06 | The President And Fellows Of Harvard College | SC-ß Zellen und Zusammensetzungen zur Erzeugung der Zellen |
WO2016021734A1 (ja) * | 2014-08-04 | 2016-02-11 | 武田薬品工業株式会社 | 膵前駆細胞の増殖方法 |
EP3234110B1 (de) | 2014-12-18 | 2024-02-28 | President and Fellows of Harvard College | Verfahren zur generierung von stammzell-abgeleiteten beta-zellen und verwendungen davon |
CN107614678B (zh) | 2014-12-18 | 2021-04-30 | 哈佛学院校长同事会 | 干细胞来源的β细胞的产生方法及其使用方法 |
WO2016100898A1 (en) | 2014-12-18 | 2016-06-23 | President And Fellows Of Harvard College | Serum-free in vitro directed differentiation protocol for generating stem cell-derived b cells and uses thereof |
CA3005694A1 (en) * | 2015-11-20 | 2017-05-26 | Qiagen Gmbh | Method of preparing sterilized compositions for stabilization of extracellular nucleic acids |
AU2018370029A1 (en) | 2017-11-15 | 2020-07-02 | Vertex Pharmaceuticals Incorporated | Islet cell manufacturing compositions and methods of use |
WO2020033879A1 (en) | 2018-08-10 | 2020-02-13 | Semma Therapeutics, Inc. | Stem cell derived islet differentiation |
JP2023520460A (ja) * | 2020-03-30 | 2023-05-17 | ザ ジョンズ ホプキンズ ユニヴァーシティー | 損傷修復の強化ならびに細菌およびウイルス感染の治療のためのカスパーゼ阻害剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6562620B2 (en) * | 1997-09-19 | 2003-05-13 | Mcgill University | Medium to promote islet cell survival |
AU2005221095A1 (en) * | 2004-03-09 | 2005-09-22 | John J. O'neil | Methods for generating insulin-producing cells |
US7807459B2 (en) * | 2005-09-27 | 2010-10-05 | Reneuron, Inc. | EphA4-positive human adult pancreatic endocrine progenitor cells |
US7875451B2 (en) * | 2006-01-19 | 2011-01-25 | The University Of Washington | Formulation to improve survival of transplanted cells |
-
2007
- 2007-01-18 DE DE602007011409T patent/DE602007011409D1/de active Active
- 2007-01-18 EP EP07718278A patent/EP1994140B1/de not_active Not-in-force
- 2007-01-18 CA CA2637843A patent/CA2637843C/en not_active Expired - Fee Related
- 2007-01-18 US US12/161,677 patent/US9745554B2/en not_active Expired - Fee Related
- 2007-01-18 JP JP2008551438A patent/JP5459823B2/ja not_active Expired - Fee Related
- 2007-01-18 AT AT07718278T patent/ATE492629T1/de not_active IP Right Cessation
- 2007-01-18 AU AU2007207434A patent/AU2007207434B2/en not_active Ceased
- 2007-01-18 WO PCT/US2007/001555 patent/WO2007084730A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP2009523449A (ja) | 2009-06-25 |
WO2007084730A3 (en) | 2007-12-27 |
US9745554B2 (en) | 2017-08-29 |
EP1994140B1 (de) | 2010-12-22 |
AU2007207434B2 (en) | 2012-04-05 |
ATE492629T1 (de) | 2011-01-15 |
CA2637843A1 (en) | 2007-07-26 |
CA2637843C (en) | 2014-12-30 |
EP1994140A2 (de) | 2008-11-26 |
AU2007207434A1 (en) | 2007-07-26 |
JP5459823B2 (ja) | 2014-04-02 |
WO2007084730A2 (en) | 2007-07-26 |
EP1994140A4 (de) | 2009-04-08 |
US20100311166A1 (en) | 2010-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602007011409D1 (de) | Verfahren für verbesserte zellproliferation von pankreas-vorläuferzellen in einer pankreaszellkultur | |
MX2019015525A (es) | Modificacion genetica de ratas. | |
ATE480615T1 (de) | Verfahren zur proliferation von stammzellen | |
GB2451523B (en) | Pluripotent cells from rat and other species | |
IN2014DN10053A (de) | ||
CL2009000782A1 (es) | Metodo que comprende un compuesto derivado de oximetilen-arilo sustituido, inhibidores de dpp-iv; y su uso en el tratamiento de la diabetes y disminucion de trigliceridos, entre otras enfermedades. | |
WO2007134294A3 (en) | Novel chlorella species and uses therefor | |
GB2452456A (en) | Cell growth medium | |
UY31222A1 (es) | Modificación enzimática del aceite | |
EP2344632A4 (de) | Verfahren zur herbeiführung von pluripotenzen in zellen | |
WO2010033906A3 (en) | Efficient induction of pluripotent stem cells using small molecule compounds | |
MX2008011838A (es) | Propagacion de celulas primarias. | |
GB2458863A (en) | Improved culture of stem cells | |
MY157524A (en) | Culturing embryonic stem cells, embryonic stem-like cells, or induced pluripotent stem cells with a muc1 or muc1* ligand | |
WO2009126251A3 (en) | Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator | |
ATE500327T1 (de) | Verfahren und zusammensetzungen für ethanolproduzierende cyanobakterien | |
SG137782A1 (en) | Membrane surface modification by radiation-induced polymerization | |
MX2010000348A (es) | Cultivo de celulas madre pluripotentes individuales. | |
MX2010002426A (es) | Agente para promover la adhesion de las celulas del endotelio corneal. | |
NZ594516A (en) | Apolipoprotein a-i mimics | |
ATE477714T1 (de) | Verfahren zur behandlung von pflanzlichem material mit einem enzym | |
EP2444527A3 (de) | Blechplattierungslösung | |
WO2012162518A3 (en) | Method for the remediation of water generated from natural resource production operations | |
UA107325C2 (uk) | Спосіб обробки декоративних рослин | |
WO2012102527A3 (ko) | 조절자 T 세포에 특이적으로 존재하는 새로운 표면단백질 Lrig-1의 용도 |